» Articles » PMID: 37093

Abrupt Withdrawal of Beta-blocking Agents in Patients with Arterial Hypertension. Effect on Blood Pressure, Heart Rate and Plasma Catecholamines and Prolactin

Overview
Specialty Pharmacology
Date 1979 Apr 17
PMID 37093
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Chronic treatment with beta-blockers was interrupted abruptly in six patients with arterial hypertension. Three patients, who had experienced symptoms during a previous withdrawal, again complained of transient palpitations, tremor, sweating, headache and general malaise. A significant increase in standing blood pressure (BP) and heart rate (HR) was noted after 24 h. The standing HR reached a maximum after 48 h and had decreased significantly on the 7th day (p less than 0.005). There was a strong tendency to greater increase in standing BP and HR in the patients who experienced symptoms than in those who did not. Plasma concentrations of noradrenaline, adrenaline and prolactin did not change significantly. Thus, beta-blocker withdrawal symptoms are reproducible and are indicative of a transient sympathetic hyperresponse. The increased activity is not likely to be caused by increased production of circulating catecholamines, but rather by increased sensitivity of the beta-receptor.

Citing Articles

KCNQ1 suppression-replacement gene therapy in transgenic rabbits with type 1 long QT syndrome.

Bains S, Giammarino L, Nimani S, Alerni N, Tester D, Kim C Eur Heart J. 2024; 45(36):3751-3763.

PMID: 39115049 PMC: 11439107. DOI: 10.1093/eurheartj/ehae476.


Drug deprescription-withdrawal risk, prevention, and treatment.

Bangert M, Aisenberg G Proc (Bayl Univ Med Cent). 2020; 33(2):213-217.

PMID: 32313464 PMC: 7155970. DOI: 10.1080/08998280.2019.1695510.


Effect of β-Adrenergic Antagonists on In-Hospital Mortality after Ischemic Stroke.

Phelan C, Alaigh V, Fortunato G, Staff I, Sansing L J Stroke Cerebrovasc Dis. 2015; 24(9):1998-2004.

PMID: 26163891 PMC: 4564292. DOI: 10.1016/j.jstrokecerebrovasdis.2015.04.035.


Preoperative depression symptom severity and its impact on adherence to preoperative beta-blocker therapy.

Schonberger R, Feinleib J, Holt N, Dai F, Brandt C, Burg M J Cardiothorac Vasc Anesth. 2014; 28(6):1467-73.

PMID: 25263776 PMC: 4258545. DOI: 10.1053/j.jvca.2014.05.006.


β-blocker withdrawal among patients presenting for surgery from home.

Schonberger R, Lukens C, Turkoglu O, Feinleib J, Haspel K, Burg M J Cardiothorac Vasc Anesth. 2012; 26(6):1029-33.

PMID: 22418043 PMC: 3419315. DOI: 10.1053/j.jvca.2012.01.024.


References
1.
Hanssen T, Heyden T, Sundberg I, Wetterberg L, Eneroth P . Decrease in serum-prolactin after propranolol in schizophrenia. Lancet. 1978; 1(8055):101-2. DOI: 10.1016/s0140-6736(78)90046-6. View

2.
Miller R, Olson H, Amsterdam E, Mason D . Propranolol-withdrawal rebound phenomenon. Exacerbation of coronary events after abrupt cessation of antianginal therapy. N Engl J Med. 1975; 293(9):416-8. DOI: 10.1056/NEJM197508282930902. View

3.
Kristensen B, Steiness E, Weeke J . Propranolol withdrawal and thyroid hormones in patients with essential hypertension. Clin Pharmacol Ther. 1978; 23(6):624-9. DOI: 10.1002/cpt1978236624. View

4.
Christensen N . Plasma noradrenaline and adrenaline in patients with thyrotoxicosis and myxoedema. Clin Sci Mol Med. 1973; 45(2):163-71. DOI: 10.1042/cs0450163. View

5.
Reid J, Wing L, Dargie H, Hamilton C, Davies D, Dollery C . Clonidine withdrawal in hypertension. Changes in blood-pressure and plasma and urinary noradrenaline. Lancet. 1977; 1(8023):1171-4. DOI: 10.1016/s0140-6736(77)92715-5. View